China
# |
Name |
Dividend Yield |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
33.86% |
Jan. 27, 2025 | USD 0.73 | -4.26% |
|
China |
|
2 |
14.94% |
Jan. 27, 2025 | USD 0.71 | 0.89% |
|
China |
|
3 |
14.78% |
Jan. 27, 2025 | USD 0.13 | -1.01% |
|
China |
|
4 |
14.13% |
Jan. 27, 2025 | USD 2.50 | 2.05% |
|
China |
|
5 |
11.12% |
Jan. 27, 2025 | USD 0.78 | -0.97% |
|
China |
|
6 |
10.80% |
Jan. 27, 2025 | USD 1.14 | 1.38% |
|
China |
|
7 |
10.13% |
Jan. 27, 2025 | USD 0.53 | 0.17% |
|
China |
|
8 |
9.85% |
Jan. 27, 2025 | USD 0.16 | -0.81% |
|
China |
|
9 |
9.75% |
Jan. 27, 2025 | USD 9.64 | 2.13% |
|
China |
|
10 |
9.38% |
Jan. 27, 2025 | USD 0.67 | 1.36% |
|
China |
|
11 |
9.07% |
Jan. 27, 2025 | USD 0.33 | 1.19% |
|
China |
|
12 |
7.73% |
Jan. 27, 2025 | USD 2.19 | 0.22% |
|
China |
|
13 |
7.60% |
Jan. 27, 2025 | USD 0.99 | 1.45% |
|
China |
|
14 |
7.57% |
Jan. 27, 2025 | USD 3.37 | -1.70% |
|
China |
|
15 |
7.55% |
Jan. 27, 2025 | USD 2.01 | -0.43% |
|
China |
|
16 |
7.16% |
Jan. 27, 2025 | USD 0.63 | 1.01% |
|
China |
|
17 |
6.30% |
Jan. 27, 2025 | USD 2.78 | -1.22% |
|
China |
|
18 |
6.28% |
Jan. 27, 2025 | USD 4.94 | 0.78% |
|
China |
|
19 |
6.18% |
Jan. 27, 2025 | USD 5.47 | -0.80% |
|
China |
|
20 |
6.14% |
Jan. 27, 2025 | USD 1.34 | -1.61% |
|
China |
|
21 |
6.04% |
Jan. 27, 2025 | USD 1.60 | 0.80% |
|
China |
|
22 |
5.94% |
Jan. 27, 2025 | USD 1.74 | -0.17% |
|
China |
|
23 |
5.86% |
Jan. 28, 2025 | USD 0.57 | -0.69% |
|
China |
|
24 |
5.77% |
Jan. 27, 2025 | USD 2.46 | -0.48% |
|
China |
|
25 |
5.58% |
Jan. 27, 2025 | USD 1.09 | 0.29% |
|
China |
|
26 |
5.57% |
Jan. 28, 2025 | USD 1.06 | -1.57% |
|
China |
|
27 |
5.55% |
Jan. 27, 2025 | USD 0.76 | 2.50% |
|
China |
|
28 |
5.51% |
Jan. 28, 2025 | USD 1.01 | 0.62% |
|
China |
|
29 |
5.51% |
Jan. 27, 2025 | USD 1.86 | 0.20% |
|
China |
|
30 |
5.49% |
Jan. 28, 2025 | USD 3.38 | -0.40% |
|
China |
|
31 |
5.37% |
Jan. 27, 2025 | USD 1.70 | 0.39% |
|
China |
|
32 |
5.19% |
Jan. 27, 2025 | USD 0.94 | -0.82% |
|
China |
|
33 |
5.18% |
Jan. 27, 2025 | USD 0.82 | 0.58% |
|
China |
|
34 |
5.16% |
Jan. 27, 2025 | USD 2.42 | 1.06% |
|
China |
|
35 |
5.13% |
Jan. 27, 2025 | USD 1.10 | 0.54% |
|
China |
|
36 |
4.94% |
Jan. 27, 2025 | USD 0.38 | -0.45% |
|
China |
|
37 |
4.70% |
Jan. 27, 2025 | USD 1.44 | -2.25% |
|
China |
|
38 |
4.63% |
Jan. 27, 2025 | USD 1.31 | 1.38% |
|
China |
|
39 |
4.38% |
Jan. 27, 2025 | USD 2.63 | 1.97% |
|
China |
|
40 |
4.36% |
Jan. 27, 2025 | USD 1.72 | 0.73% |
|
China |
|
41 |
4.29% |
Jan. 28, 2025 | USD 1.46 | -0.02% |
|
China |
|
42 |
4.29% |
Jan. 27, 2025 | USD 4.21 | 1.60% |
|
China |
|
43 |
4.26% |
Jan. 27, 2025 | USD 1.31 | 0.65% |
|
China |
|
44 |
4.26% |
Jan. 27, 2025 | USD 3.06 | 1.51% |
|
China |
|
45 |
4.25% |
Jan. 27, 2025 | USD 4.96 | 0.66% |
|
China |
|
46 |
3.95% |
Jan. 27, 2025 | USD 1.78 | -0.33% |
|
China |
|
47 |
3.93% |
Jan. 27, 2025 | USD 1.22 | -0.65% |
|
China |
|
48 |
3.92% |
Jan. 27, 2025 | USD 0.64 | -1.01% |
|
China |
|
49 |
3.92% |
Jan. 27, 2025 | USD 1.44 | 1.17% |
|
China |
|
50 |
3.91% |
Jan. 27, 2025 | USD 2.25 | 1.02% |
|
China |
The Healthcare company in China with the highest Dividend Yield is Daan Gene Co., Ltd. (Shenzhen Stock Exchange: 002030.SZ) at 33.86%.
The Healthcare company in China with the lowest Dividend Yield is Keymed Biosciences Inc. (HKSE: 2162.HK) at 0.00%.
The top 10 Healthcare companies in China by Dividend Yield are Daan Gene Co., Ltd., C.Q. Pharmaceutical Holding Co., Ltd., Zhongzhi Pharmaceutical Holdings Limited, Wuhan Easy Diagnosis Biomedicine Co.,Ltd., Shanghai Kehua Bio-Engineering Co.,Ltd, Luyan Pharma Co.,Ltd., Huapont Life Sciences Co., Ltd., Rici Healthcare Holdings Limited, Hangzhou Alltest Biotech Co., Ltd. and NanJing Pharmaceutical Company Limited.
The bottom 10 Healthcare companies in China by Dividend Yield are Keymed Biosciences Inc., HBM Holdings Limited, Shanghai Junshi Biosciences Co., Ltd., Innovent Biologics, Inc., Hua Medicine (Shanghai) Ltd., Kangmei Pharmaceutical Co., Ltd., Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Kindstar Globalgene Technology, Inc., ClouDr Group Limited and Ascentage Pharma Group International.